Witnessing the stock’s movement on the chart, on Wednesday, Arvinas Inc (NASDAQ: ARVN) set off with pace as it heaved 4.84% to $9.75, before settling in for the price of $9.3 at the close. Taking a more long-term approach, ARVN posted a 52-week range of $5.90-$29.61.
The Healthcare sector firm’s twelve-monthly sales growth has been -5.32% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -5.32%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 61.43%. This publicly-traded company’s shares outstanding now amounts to $73.20 million, simultaneously with a float of $64.24 million. The organization now has a market capitalization sitting at $715.82 million. At the time of writing, stock’s 50-day Moving Average stood at $7.74, while the 200-day Moving Average is $10.44.
Arvinas Inc (ARVN) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Arvinas Inc’s current insider ownership accounts for 12.51%, in contrast to 91.64% institutional ownership. According to the most recent insider trade that took place on Sep 22 ’25, this organization’s Director bought 30,000 shares at the rate of 7.57, making the entire transaction reach 227,010 in total value, affecting insider ownership by 76,021. Preceding that transaction, on Jun 24 ’25, Company’s Chief Financial Officer sold 5,700 for 7.61, making the whole transaction’s value amount to 43,377. This particular insider is now the holder of 164,401 in total.
Arvinas Inc (ARVN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.6 per share during the current fiscal year.
Arvinas Inc’s EPS increase for this current 12-month fiscal period is 61.43% and is forecasted to reach -3.01 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -2.93% through the next 5 years, which can be compared against the -5.32% growth it accomplished over the previous five years trading on the market.
Arvinas Inc (NASDAQ: ARVN) Trading Performance Indicators
Let’s observe the current performance indicators for Arvinas Inc (ARVN). It’s Quick Ratio in the last reported quarter now stands at 5.64. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.45.
In the same vein, ARVN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.08, a figure that is expected to reach -0.71 in the next quarter, and analysts are predicting that it will be -3.01 at the market close of one year from today.
Technical Analysis of Arvinas Inc (ARVN)
Going through the that latest performance of [Arvinas Inc, ARVN]. Its last 5-days volume of 2.09 million was inferior to the volume of 2.14 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 78.85% While, its Average True Range was 79.20.
Raw Stochastic average of Arvinas Inc (ARVN) in the period of the previous 100 days is set at 91.73%, which indicates a major rise in contrast to 87.82% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.49 that was higher than 0.41 volatility it exhibited in the past 100-days period.
